Immunotherapy Advances in Gastroesophageal Cancers

 

Baylor Charles A. Sammons Cancer Center
R

Adjuvant Nivo in Resected EC/GEJC Following Neoadjuvant CRT: 14-Month Follow-Up of CheckMate 577

By Baylor Charles A. Sammons Cancer Center FEATURING Ronan Kelly
By Baylor Charles A. Sammons Cancer Center FEATURING Ronan Kelly
447 views
March 9, 2022
0 Comments
Login to view comments. Click here to Login
Immunotherapy Advances in Gastroesophageal Cancers
08:15
ASCO GI 2022 Conference Coverage

ASCO GI 2022 on a Quality-Adjusted Time Without Symptoms or Toxicity…

Feat. R. Sugarman
08:49
ASCO GI 2022 Conference Coverage

ASCO GI 2022 Update on NIVO+ Chemo vs Chemo as 1L Treatment for Adva…

Feat. K. Shitara
20:21
ASCO GI 2022 Conference Coverage

ASCO GI 2022 Review of the Emerging Roles of ctDNA as a Tool for Ear…

Feat. N. Starling
08:47
Cleveland Clinic Taussig Cancer Institute

Immunotherapy Advances in Gastric and Esophageal Cancers

Feat. S. Kamath
06:47
Baylor Charles A. Sammons Cancer Center

Adjuvant Nivo in Resected EC/GEJC Following Neoadjuvant CRT: 14-Mont…

Feat. R. Kelly
22:24
UNC Lineberger Comprehensive Cancer Center

Updates in Molecular Therapy for Gastroesophageal Cancers

Feat. H. K. Sanoff
47:09
Adarsh M. Thaker

Barrett's Esophagus: Managing the Link Between Acid Reflux &…

17:36
2022 West Oncology Conference

The Evolving Role for IO in Upper GI Malignancies and Updates in Neu…

Feat. S. Das
42:35
Debbie's Dream Foundation

Upper GI Cancers: New Combinations With IO and Targeted Therapy

Feat. Z. Wainberg
31:19
Debbie's Dream Foundation

Immunotherapy for Gastric Cancer: At the Frontier

Feat. P. Boland
08:40
Cedars Sinai

PD-L1 CPS As a Biomarker for Patient Selection for Immunotherapy in …

Feat. J. Gong